
#26 - Andrew Huberman
The Network State Podcast
00:00
Balancing innovation and informed consent
They debate stem cell risks, informed consent, pharmacogenomics, organoids, and using proxies to predict patient responses.
Play episode from 01:02:15
Transcript


